Seth Klarman portfolio · Q1 2014
The Baupost Group, L.L.C. · CIK 0001061768 ·13F filings on SEC EDGAR
In Q1 2014, The Baupost Group, L.L.C. reported 20 positions worth $4.1B. Its largest holding was MU at 29.5% of the portfolio, and the top 10 made up 92%. Its largest new position was LNG ($313.3M), and it sold out of 31620R105.
- NEW 4
- ADD 4
- REDUCE 2
- EXIT 3
Portfolio map
Each box is a position sized by its value. Color shows the change in shares from the previous quarter.
Portfolio history
Q2 2013 to Q1 2014, 4 quarters
Weight of the largest holdings
The 7 holdings with the highest weight in any quarter shown, stacked with all others to 100%.
Holding timeline
Shade shows the weight in each quarter. A blank cell means the holding was not reported that quarter.
Holdings
Click a holding to see its price chart with the quarters the investor bought or sold.
| Name | Weight | Avg. cost (est.) | Latest price | Gain/loss | Value |
|---|---|---|---|---|---|
MU MICRON TECHNOLOGY INC | 29.54% | $15.43* | $1,065.11 | +6,801.3% | $55B |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
VSAT VIASAT INC | 19.02% | $71.30* | $70.38 | -1.3% | $802M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
88338T104 THERAVANCE INC | 15.49% | $38.32* | $10.54 | -72.5% | $218.2M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
LNG CHENIERE ENERGY INC | 7.57% | $55.35 | $403.55 | +629.1% | $2.3B |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
IDIX IDENIX PHARMACEUTICALS LLC | 7.32% | $4.65* | $23.81 | +411.4% | $1.3B |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
BP BP PLC-SPONS ADR | 3.68% | $41.82* | $43.99 | +5.2% | $139.3M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
PBF PBF ENERGY INC-CLASS A | 3.38% | $26.28 | $76.96 | +192.9% | $416.9M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
KERX KERYX BIOPHARMACEUTICALS | 2.60% | $17.04 | $3.40 | -80.0% | $21.5M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
NG NOVAGOLD RESOURCES INC | 1.89% | $2.11* | $6.50 | +208.1% | $141M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
G2110R114 CHIPMOS TECH BERMUDA LTD | 1.75% | $19.13* | $19.80 | +3.5% | $65M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
C.WS.A CITIGROUP INC-CW19 | 1.62% | $0.77* | $0.15 | -80.3% | $15.8M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
RFMD RF MICRO DEVICES INC | 1.25% | $7.88 | $11.54 | +46.4% | $76M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
TQNT QORVO US INC | 1.24% | $13.39 | $19.07 | +42.4% | $72.9M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
KIN KINDRED BIOSCIENCES INC | 1.24% | $11.17 | $9.17 | -17.9% | $25.3M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
ELOS SYNERON MEDICAL LTD | 1.20% | $8.70* | $10.95 | +25.9% | $43.8M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
018772103 ALLIANCE ONE INTL INC | 0.45% | $3.80* | $1.10 | -71.1% | $7M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
AIG.WS AMERICAN INTERNATIONAL-CW21 | 0.32% | — | $0.16 | — | $105K |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
66988K102 NOVACOPPER INC | 0.16% | $1.75* | $0.50 | -71.4% | $2.5M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
053588109 AVEO PHARMACEUTICALS INC | 0.14% | $2.50* | $2.26 | -9.6% | $8.7M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
ALDW ALON USA PARTNERS LP | 0.13% | $16.66 | $23.31 | +39.9% | $7.7M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
Average cost is an estimate, not the investor's actual purchase price: every quarter the share count rose, the added shares are counted at that quarter-end's 13F price, and sales keep the average. Latest price is the most recent 13F quarter-end price (Sep 30, 2026), and value is shares × latest price. * Held since before Jun 30, 2013, when our collected history starts, so the average starts from that quarter's price.
Changes in shares
Change in shares held vs Dec 31, 2013, for the 13 largest positions that changed. Bars are capped at ±100%; the label shows the actual change.
Sold out this quarter
Held on Dec 31, 2013 and not reported for Q1 2014.
SEC filings for Q1 2014
- 13F-HR 0001140361-14-020929 · accepted May 14, 2014, 20:24 UTC